Annual D&A
$3.50 M
-$1.99 M-36.25%
31 December 2023
Summary:
Inovio Pharmaceuticals annual depreciation & amortization is currently $3.50 million, with the most recent change of -$1.99 million (-36.25%) on 31 December 2023. During the last 3 years, it has fallen by -$1.12 million (-24.29%). INO annual D&A is now -36.49% below its all-time high of $5.52 million, reached on 31 December 2019.INO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$765.90 K
-$62.70 K-7.57%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly depreciation & amortization is currently $765.90 thousand, with the most recent change of -$62.70 thousand (-7.57%) on 30 September 2024. Over the past year, it has dropped by -$266.90 thousand (-25.84%). INO quarterly D&A is now -61.13% below its all-time high of $1.97 million, reached on 31 December 2019.INO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.53 M
-$266.90 K-9.54%
30 September 2024
Summary:
Inovio Pharmaceuticals TTM depreciation & amortization is currently $2.53 million, with the most recent change of -$266.90 thousand (-9.54%) on 30 September 2024. Over the past year, it has dropped by -$2.15 million (-45.92%). INO TTM D&A is now -54.32% below its all-time high of $5.54 million, reached on 31 March 2020.INO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.3% | -25.8% | -45.9% |
| 3 y3 years | -24.3% | -33.7% | -51.8% |
| 5 y5 years | -29.9% | -33.4% | -47.2% |
INO Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -36.3% | at low | -45.7% | +337.2% | -54.2% | at low |
| 5 y | 5 years | -36.5% | at low | -61.1% | +337.2% | -54.3% | at low |
| alltime | all time | -36.5% | +775.9% | -61.1% | +665.9% | -54.3% | +2429.4% |
Inovio Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $765.90 K(-7.6%) | $2.53 M(-9.5%) |
| June 2024 | - | $828.60 K(+9.1%) | $2.80 M(-10.1%) |
| Mar 2024 | - | $759.70 K(+333.6%) | $3.11 M(-11.2%) |
| Dec 2023 | $3.50 M(-36.3%) | $175.20 K(-83.0%) | $3.50 M(-25.1%) |
| Sept 2023 | - | $1.03 M(-9.7%) | $4.68 M(-6.6%) |
| June 2023 | - | $1.14 M(-0.8%) | $5.01 M(-5.1%) |
| Mar 2023 | - | $1.15 M(-14.6%) | $5.27 M(-4.1%) |
| Dec 2022 | $5.50 M(+16.2%) | $1.35 M(-1.0%) | $5.50 M(-0.6%) |
| Sept 2022 | - | $1.36 M(-3.4%) | $5.53 M(+3.9%) |
| June 2022 | - | $1.41 M(+2.5%) | $5.32 M(+5.8%) |
| Mar 2022 | - | $1.38 M(-0.3%) | $5.03 M(+6.3%) |
| Dec 2021 | $4.73 M(+2.2%) | $1.38 M(+19.4%) | $4.73 M(-9.8%) |
| Sept 2021 | - | $1.16 M(+3.1%) | $5.25 M(+6.1%) |
| June 2021 | - | $1.12 M(+4.2%) | $4.94 M(+10.2%) |
| Mar 2021 | - | $1.08 M(-43.2%) | $4.49 M(-3.1%) |
| Dec 2020 | $4.63 M(-16.1%) | $1.89 M(+122.2%) | $4.63 M(-1.6%) |
| Sept 2020 | - | $852.20 K(+28.4%) | $4.70 M(-5.9%) |
| June 2020 | - | $663.60 K(-45.5%) | $5.00 M(-9.7%) |
| Mar 2020 | - | $1.22 M(-38.2%) | $5.54 M(+0.4%) |
| Dec 2019 | $5.52 M(+10.4%) | $1.97 M(+71.4%) | $5.52 M(+15.1%) |
| Sept 2019 | - | $1.15 M(-4.1%) | $4.79 M(-0.9%) |
| June 2019 | - | $1.20 M(+0.1%) | $4.84 M(-1.2%) |
| Mar 2019 | - | $1.20 M(-3.9%) | $4.89 M(-2.1%) |
| Dec 2018 | $5.00 M(+44.0%) | $1.25 M(+4.4%) | $5.00 M(+18.3%) |
| Sept 2018 | - | $1.19 M(-5.0%) | $4.23 M(+0.7%) |
| June 2018 | - | $1.26 M(-3.5%) | $4.20 M(+9.2%) |
| Mar 2018 | - | $1.30 M(+174.4%) | $3.84 M(+10.8%) |
| Dec 2017 | $3.47 M(+12.4%) | $474.40 K(-59.2%) | $3.47 M(-9.2%) |
| Sept 2017 | - | $1.16 M(+28.9%) | $3.82 M(+8.1%) |
| June 2017 | - | $902.60 K(-2.8%) | $3.53 M(+3.4%) |
| Mar 2017 | - | $928.60 K(+12.7%) | $3.42 M(+10.7%) |
| Dec 2016 | $3.09 M(+60.8%) | $824.30 K(-6.1%) | $3.09 M(+10.7%) |
| Sept 2016 | - | $877.80 K(+11.6%) | $2.79 M(+15.8%) |
| June 2016 | - | $786.50 K(+31.7%) | $2.41 M(+15.9%) |
| Mar 2016 | - | $597.40 K(+13.4%) | $2.08 M(+8.3%) |
| Dec 2015 | $1.92 M(+22.3%) | $526.90 K(+5.8%) | $1.92 M(+5.4%) |
| Sept 2015 | - | $497.80 K(+9.0%) | $1.82 M(+4.5%) |
| June 2015 | - | $456.50 K(+4.3%) | $1.74 M(+5.5%) |
| Mar 2015 | - | $437.50 K(+2.1%) | $1.65 M(+5.2%) |
| Dec 2014 | $1.57 M(-25.2%) | $428.40 K(+2.2%) | $1.57 M(-12.0%) |
| Sept 2014 | - | $419.30 K(+14.5%) | $1.78 M(-3.5%) |
| June 2014 | - | $366.30 K(+3.1%) | $1.85 M(-6.1%) |
| Mar 2014 | - | $355.30 K(-44.7%) | $1.97 M(-6.3%) |
| Dec 2013 | $2.10 M(+5.2%) | $642.10 K(+32.9%) | $2.10 M(+7.3%) |
| Sept 2013 | - | $483.20 K(-0.6%) | $1.96 M(-0.9%) |
| June 2013 | - | $486.30 K(-0.3%) | $1.97 M(-0.5%) |
| Mar 2013 | - | $487.80 K(-2.5%) | $1.99 M(-0.5%) |
| Dec 2012 | $1.99 M(-0.8%) | $500.10 K(-0.0%) | $1.99 M(-0.1%) |
| Sept 2012 | - | $500.30 K(+0.6%) | $2.00 M(-0.1%) |
| June 2012 | - | $497.10 K(-0.1%) | $2.00 M(-0.3%) |
| Mar 2012 | - | $497.40 K(-1.1%) | $2.01 M(-0.3%) |
| Dec 2011 | $2.01 M | $503.00 K(+0.3%) | $2.01 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $501.50 K(-0.4%) | $2.03 M(-1.3%) |
| June 2011 | - | $503.40 K(-0.1%) | $2.06 M(-1.3%) |
| Mar 2011 | - | $503.80 K(-4.3%) | $2.09 M(-0.9%) |
| Dec 2010 | $2.11 M(+25.7%) | $526.20 K(-0.6%) | $2.11 M(-1.4%) |
| Sept 2010 | - | $529.20 K(-0.2%) | $2.14 M(-1.1%) |
| June 2010 | - | $530.50 K(+1.5%) | $2.16 M(+9.6%) |
| Mar 2010 | - | $522.60 K(-6.1%) | $1.97 M(+17.6%) |
| Dec 2009 | $1.68 M(+68.9%) | $556.50 K(+0.7%) | $1.68 M(+23.6%) |
| Sept 2009 | - | $552.50 K(+62.4%) | $1.36 M(+29.0%) |
| June 2009 | - | $340.30 K(+49.5%) | $1.05 M(+7.1%) |
| Mar 2009 | - | $227.70 K(-3.5%) | $981.80 K(-1.1%) |
| Dec 2008 | $993.00 K(+4.0%) | $235.90 K(-4.8%) | $993.00 K(+3.0%) |
| Sept 2008 | - | $247.70 K(-8.4%) | $964.00 K(-3.5%) |
| June 2008 | - | $270.50 K(+13.2%) | $999.30 K(+3.8%) |
| Mar 2008 | - | $238.90 K(+15.5%) | $962.90 K(+0.9%) |
| Dec 2007 | $954.60 K(+4.7%) | $206.90 K(-26.9%) | $954.60 K(+5.2%) |
| Sept 2007 | - | $283.00 K(+20.9%) | $907.00 K(-1.0%) |
| June 2007 | - | $234.10 K(+1.5%) | $916.20 K(+2.5%) |
| Mar 2007 | - | $230.60 K(+44.8%) | $894.10 K(-1.9%) |
| Dec 2006 | $911.60 K(+14.0%) | $159.30 K(-45.5%) | $911.70 K(-0.5%) |
| Sept 2006 | - | $292.20 K(+37.8%) | $916.40 K(+7.4%) |
| June 2006 | - | $212.00 K(-14.6%) | $853.10 K(-0.4%) |
| Mar 2006 | - | $248.20 K(+51.3%) | $856.50 K(+7.2%) |
| Dec 2005 | $799.30 K(+39.5%) | $164.00 K(-28.4%) | $799.30 K(+1.4%) |
| Sept 2005 | - | $228.90 K(+6.3%) | $788.50 K(+11.7%) |
| June 2005 | - | $215.40 K(+12.8%) | $705.90 K(+12.0%) |
| Mar 2005 | - | $191.00 K(+24.7%) | $630.10 K(+9.9%) |
| Dec 2004 | $573.00 K(-2.0%) | $153.20 K(+4.7%) | $573.10 K(-0.1%) |
| Sept 2004 | - | $146.30 K(+4.8%) | $573.90 K(+0.2%) |
| June 2004 | - | $139.60 K(+4.2%) | $572.80 K(-0.4%) |
| Mar 2004 | - | $134.00 K(-13.0%) | $575.00 K(-1.6%) |
| Dec 2003 | $584.40 K(-5.6%) | $154.00 K(+6.1%) | $584.40 K(+1.5%) |
| Sept 2003 | - | $145.20 K(+2.4%) | $575.50 K(-3.3%) |
| June 2003 | - | $141.80 K(-1.1%) | $595.00 K(-2.3%) |
| Mar 2003 | - | $143.40 K(-1.2%) | $608.70 K(-1.7%) |
| Dec 2002 | $619.30 K(+16.8%) | $145.10 K(-11.9%) | $619.30 K(+30.6%) |
| Sept 2002 | - | $164.70 K(+5.9%) | $474.20 K(-1.4%) |
| June 2002 | - | $155.50 K(+1.0%) | $480.70 K(-3.2%) |
| Mar 2002 | - | $154.00 K(-10.0%) | $496.50 K(-27.5%) |
| Dec 2001 | $530.20 K(-15.0%) | - | - |
| Sept 2001 | - | $171.20 K(-0.1%) | $684.70 K(+3.8%) |
| June 2001 | - | $171.30 K(-13.1%) | $659.50 K(+5.8%) |
| Mar 2001 | - | $197.10 K(+35.8%) | $623.50 K(+5.2%) |
| Mar 2001 | $623.50 K(+10.1%) | - | - |
| Dec 2000 | - | $145.10 K(-0.6%) | $592.80 K(-8.5%) |
| Sept 2000 | - | $146.00 K(+7.9%) | $647.70 K(+7.6%) |
| June 2000 | - | $135.30 K(-18.7%) | $601.70 K(+6.2%) |
| Mar 2000 | $566.40 K(+41.6%) | $166.40 K(-16.8%) | $566.40 K(+41.6%) |
| Dec 1999 | - | $200.00 K(+100.0%) | $400.00 K(+100.0%) |
| Sept 1999 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| June 1999 | - | $100.00 K | $100.00 K |
| Mar 1999 | $400.00 K | - | - |
FAQ
- What is Inovio Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual D&A year-on-year change?
- What is Inovio Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly D&A year-on-year change?
- What is Inovio Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals TTM D&A year-on-year change?
What is Inovio Pharmaceuticals annual depreciation & amortization?
The current annual D&A of INO is $3.50 M
What is the all time high annual D&A for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual depreciation & amortization is $5.52 M
What is Inovio Pharmaceuticals annual D&A year-on-year change?
Over the past year, INO annual depreciation & amortization has changed by -$1.99 M (-36.25%)
What is Inovio Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of INO is $765.90 K
What is the all time high quarterly D&A for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly depreciation & amortization is $1.97 M
What is Inovio Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, INO quarterly depreciation & amortization has changed by -$266.90 K (-25.84%)
What is Inovio Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of INO is $2.53 M
What is the all time high TTM D&A for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high TTM depreciation & amortization is $5.54 M
What is Inovio Pharmaceuticals TTM D&A year-on-year change?
Over the past year, INO TTM depreciation & amortization has changed by -$2.15 M (-45.92%)